Freshpet (FRPT) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
31 Aug, 2026Executive summary
Net sales grew 13.1% year-over-year to $297.6 million in Q1 2026, driven by volume gains, manufacturing scale, product diversity, and omnichannel reach.
Net income reached $48.5 million, reversing a net loss of $12.7 million in the prior year, aided by a $62.0 million gain on the sale of an equity investment and higher sales.
Adjusted EBITDA was $37.9 million, up $2.4 million year-over-year; margin was 12.7% versus 13.5% last year.
Continued to gain market share in the fresh pet food category, leveraging new technologies, operational effectiveness, and expanding household penetration.
Focused on operational effectiveness, capital efficiency, and new technology to support long-term growth.
Financial highlights
Gross profit was $120.7 million (40.5% of net sales), up from $103.8 million (39.4%) year-over-year.
Adjusted gross margin improved to 46.9% from 45.7% year-over-year.
Adjusted EBITDA margin was 12.7% (down from 13.5% last year).
Free cash flow was $12.7 million, a $34.4 million increase year-over-year.
Cash and cash equivalents rose to $381.4 million, mainly from the equity investment sale.
Outlook and guidance
Raised 2026 net sales growth guidance to 8%–11% (from 7%–10%).
Adjusted EBITDA guidance remains at $205–$215 million, with sequential improvement expected.
Capital expenditures projected at ~$150 million, with flexibility for technology or distribution expansion.
Anticipates being free cash flow positive in 2026.
2027 targets: net sales growth above category, at least 48% adjusted gross margin, and 20%–22% adjusted EBITDA margin.
Latest events from Freshpet
- Omni-channel growth, innovation, and margin expansion position the business to lead fresh pet food.FRPT
Barclays 19th Annual Global Consumer Conference - Q2 2026 net sales up 15.5%, margin and EBITDA guidance raised on omni-channel and innovation gains.FRPT
Q2 2026 - 2025 net sales rose 13% to $1.1B, with strong cash flow and 2026 growth guidance of 7–10%.FRPT
Q4 2025 - Q3 2025 sales up 14%, EBITDA and net income surge, free cash flow positive, guidance narrowed.FRPT
Q3 2025 - Q2 2025 net sales rose 12.5% with margin gains, capex cuts, and reaffirmed profitability targets.FRPT
Q2 2025 - Q3 net sales up 26%, margins expanded, and 2024 guidance raised on strong execution.FRPT
Q3 2024 - Q2 2024 net sales up 28.3% with margin gains and raised full-year guidance.FRPT
Q2 2024 - Q1 net sales up 18%, but net loss and reduced outlook reflect higher costs and headwinds.FRPT
Q1 2025 - Record sales, margin gains, and first positive net income drive upgraded long-term targets.FRPT
Q4 2024